Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Vincristine × 90 days × Clear all

Sponsor

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Burkitt Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 15 Lymphoma, Follicular 10 Lymphoma 8 Sarcoma, Ewing 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 7 Rhabdomyosarcoma 6 Neoplasms 5 Leukemia, Biphenotypic, Acute 5 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4 Neuroblastoma 4 Medulloblastoma 4 Lymphoma, Mantle-Cell 4 Lymphoma, B-Cell, Marginal Zone 4 Lymphoma, B-Cell 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Sarcoma 3 Recurrence 3 Osteosarcoma 3 Lymphoma, Non-Hodgkin 3 Leukemia 3 Hodgkin Disease 3 Wilms Tumor 2 Rhabdomyosarcoma, Embryonal 2 Oligodendroglioma 2 Ganglioneuroblastoma 2 Desmoplastic Small Round Cell Tumor 2 Waldenstrom Macroglobulinemia 1 Stage I Mixed Cell Type Kidney Wilms Tumor 1

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cholecalciferol 1 Azacitidine 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡